Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals initiates phase 2 development program for Aurora kinase inhibitor
Published in Health Business Week, May 5th, 2006
In connection with the initiation of phase 2 development, Vertex earned a $10 million milestone payment in March 2006 from Merck & Co., Inc. Vertex and Merck have a global collaboration to develop and commercialize VX-680.
The initiation of phase 2 development for VX-680 is based on the enrollment of patients with advanced colorectal cancer in a phase 2 extension of a previous phase 1 clinical study. In addition, Merck expects to initiate a phase 2 clinical study for...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
Source: Health Business Week (2006-05-05)
More Articles from Health Business Week
- 7TM Pharma A/S
7TM Pharma raises EUR 19 million in a Series C financing round - AMDL, Inc.
AMDL reports 2.6% increase in revenue - AMS Health Sciences, Inc.
AMS Health Sciences reports AMEX's acceptance of its plan to regain compliance - Aastrom Biosciences, Inc.
Aastrom Biosciences raises $25.5 million in equity financing - Affinergy, Inc.
Affinergy receives SBIR grant to accelerate research on medical device materials - Arrow International
Arrow International reports earnings of $0.28 per share - More from this issue of Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
